VANGUARD GROUP INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 107 filers reported holding HERON THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,414,359
-10.9%
8,169,280
+0.4%
0.00%
Q2 2023$9,443,237
-25.8%
8,140,722
-3.4%
0.00%
Q1 2023$12,730,233
-34.8%
8,430,618
+8.0%
0.00%
-100.0%
Q4 2022$19,515,712
-47.2%
7,806,285
-10.8%
0.00%0.0%
Q3 2022$36,938,000
+66.3%
8,752,841
+9.9%
0.00%0.0%
Q2 2022$22,214,000
-60.9%
7,962,197
-19.9%
0.00%0.0%
Q1 2022$56,827,000
-35.2%
9,934,688
+3.4%
0.00%
-50.0%
Q4 2021$87,730,000
-13.6%
9,609,045
+1.1%
0.00%
-33.3%
Q3 2021$101,558,000
-29.8%
9,500,292
+1.9%
0.00%
-25.0%
Q2 2021$144,643,000
+5.1%
9,319,728
+9.8%
0.00%0.0%
Q1 2021$137,642,000
-21.8%
8,491,216
+2.2%
0.00%
-20.0%
Q4 2020$175,919,000
+48.4%
8,311,768
+3.9%
0.01%
+25.0%
Q3 2020$118,577,000
+0.4%
8,001,099
-0.4%
0.00%0.0%
Q2 2020$118,115,000
+26.0%
8,029,538
+0.6%
0.00%0.0%
Q1 2020$93,738,000
-49.2%
7,984,465
+1.6%
0.00%
-33.3%
Q4 2019$184,628,000
+43.5%
7,856,566
+12.9%
0.01%
+20.0%
Q3 2019$128,687,000
+2.6%
6,956,047
+3.1%
0.01%0.0%
Q2 2019$125,387,000
-20.0%
6,744,858
+5.2%
0.01%
-16.7%
Q1 2019$156,770,000
-4.3%
6,414,507
+1.6%
0.01%
-14.3%
Q4 2018$163,794,000
-16.4%
6,314,339
+2.0%
0.01%
-12.5%
Q3 2018$196,016,000
+11.3%
6,193,249
+36.7%
0.01%
+14.3%
Q2 2018$176,066,000
+128.1%
4,531,931
+62.0%
0.01%
+133.3%
Q1 2018$77,203,000
+76.4%
2,797,188
+15.7%
0.00%
+50.0%
Q4 2017$43,754,000
+30.9%
2,417,280
+16.8%
0.00%0.0%
Q3 2017$33,422,000
+15.1%
2,069,493
-1.3%
0.00%
+100.0%
Q2 2017$29,036,000
+3.2%
2,096,465
+11.8%
0.00%0.0%
Q1 2017$28,127,000
+60.5%
1,875,103
+40.2%
0.00%0.0%
Q4 2016$17,522,000
-22.4%
1,337,540
+2.0%
0.00%0.0%
Q3 2016$22,588,000
+3.0%
1,310,980
+7.9%
0.00%0.0%
Q2 2016$21,937,000
-0.2%
1,215,343
+5.0%
0.00%0.0%
Q1 2016$21,978,000
-25.3%
1,157,304
+5.0%
0.00%
-50.0%
Q4 2015$29,433,000
-84.1%
1,102,364
-82.7%
0.00%
-71.4%
Q3 2015$184,862,000
+562.6%
6,377,962
+612.4%
0.01%
+250.0%
Q2 2015$27,898,000
+186.5%
895,326
+33.8%
0.00%
+100.0%
Q1 2015$9,738,000
+68.1%
669,311
+16.2%
0.00%
Q4 2014$5,793,000
+23.2%
575,807
+2.0%
0.00%
Q3 2014$4,702,000
-21.6%
564,533
+15.9%
0.00%
Q2 2014$5,999,000486,9240.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders